Pfizer’s COVID-19 booster vaccine, pneumococcal jab tested in older adults

The first participants aged 65 and older have received vaccinations in a new study assessing coadministration of a pneumococcal jab along with a COVID-19 booster shot, Pfizer announced on Monday.